Cannabis use amongst patients with inflammatory bowel disease

European Journal of Gastroenterology and Hepatology

Volumn 23, Issue 10, 2011, Pages 891-896

  Lal, Simon ^a,b   Prasad, Neeraj ^b   Ryan, Manijeh ^a   Tangri, Sabrena ^a   Silverberg, Mark S ^a   Gordon, Allan ^a   Steinhart, Hillary ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

cannabis; complimentary alternative medicine; Crohn's disease; inflammatory bowel diseases; ulcerative colitis

Indexed keywords

ANALGESIC AGENT; CANNABIS;

ABDOMINAL PAIN; ABDOMINAL SURGERY; ACUPUNCTURE; ADULT; ALTERNATIVE MEDICINE; AMNESIA; ANOREXIA; ANXIETY; AROMATHERAPY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; CROSS-SECTIONAL STUDY; DEPRESSION; DIARRHEA; DROWSINESS; ENTERITIS; FEMALE; HALLUCINATION; HEART PALPITATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OUTPATIENT; PALLIATIVE THERAPY; PARANOIA; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SIDE EFFECT; SOCIAL STATUS; ULCERATIVE COLITIS; XEROSTOMIA;

ADULT; CANNABIS; COLITIS, ULCERATIVE; COMPLEMENTARY THERAPIES; CROHN DISEASE; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; ONTARIO; PHYTOTHERAPY; PLANT EXTRACTS; QUALITY OF LIFE; SELF MEDICATION;

EID: 80052657049     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328349bb4c     Document Type: Article

References (28)

1. Canadian Alcohol and Drug Use Monitoring Survey 2009.
2. Baker D, Pryce G, Giovannoni G, Thompson AJ. The therapeutic potential of cannabis. Lancet Neurol 2003; 2: 291-298. (Pubitemid 38368569)
3. Page SA, Verhoef MJ, Stebbins RA, Metz LM, Levy JC. Cannabis use as described by people with multiple sclerosis. Can J Neurol Sci 2003; 30:201-205. (Pubitemid 37064512)
4. Woolridge E, Barton S, Samuel J, Osorio J, Dougherty A, Holdcroft A. Cannabis use in HIV for pain and other medical symptoms. J Pain Symptom Manage 2005; 29:358-367. (Pubitemid 40602516)
5. Ogborne AC, Smart RG, Adlaf EM. Self-reported medical use of marijuana: a survey of the general population. CMAJ 2000; 162:1685-1686. (Pubitemid 30422307)
6. Garcia-Planella E, Marin L, Domenech E, Bernal I, Manosa M, Zabana Y, Gassull MA. Use of complementary and alternative medicine and drug abuse in patients with inflammatory bowel disease. Med Clin (Barc). 2007; 128: pp. 45-48.
7. Duncan M, Davison JS, Sharkey KA. Review article: endocannabinoids and their receptors in the enteric nervous system. Aliment Pharmacol Ther 2005; 22:667-683. (Pubitemid 41475329)
8. Izzo AA, Camilleri M. Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects. Gut 2008; 57:1140-1155.
9. Izzo AA, Sharkey KA. Cannabinoids and the gut: new developments and emerging concepts. Pharmacol Ther 2010; 126:21-38.
10. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19 (Suppl A):5-36.
11. Ewing JA. Detecting alcoholism. The CAGE questionnaire. JAMA 1984; 252:1905-1907. (Pubitemid 14002155)
12. Irvine EJ, Zhou Q, Thompson AK. The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians.
13. Sanson M, Bueno L, Fioramonti J. Involvement of cannabinoid receptors to colonic distension in rats. Neurogastroenterol Motil 2006; 18: 949-956. (Pubitemid 44358865)
14. Izzo AA, Capasso F, Costagliola A, Bisogna T, Marsicano G, Ligresti A, et al. An endogenous cannabinoid tone attenuates cholera toxin-induced fluid accumulation in mice. Gastroenterology 2003; 125:765-774. (Pubitemid 37070694)
15. Ihenetu K, Molleman A, Parsons ME, Whelan CJ. Inhibition of interleukin-8 release in the human colonic epithelial cell line HT-29 by cannabinoids. Eur J Pharmacol 2003; 458:207-215. (Pubitemid 36050722)
16. Beal JE, Olson R, Laubenstein L, Morales JO, Bellman P, Yangco B, et al. Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J pain Symptom Manage 1995; 10:89-97.
17. Quattropani C, Ausfeld B, Straumann A, Heer P, Seibold F. Complementary alternative medicine in patients with inflammatory bowel disease: use and attitudes. Scand J Gastroenterol 2003; 38:277-282. (Pubitemid 36469987)
18. Kong SC, Hurlstone DP, Pocock CY, Walkington LA, Farquharson NR, Bramble MG, et al. The Incidence of self-prescribed oral complementary and alternative medicine use by patients with gastrointestinal diseases. J Clin Gastroenterol 2005; 39:138-141. (Pubitemid 40130027)
19. Rawsthorne P, Shanahan F, Cronin NC, Anton PA, Lofberg R, Bohman L, Bernstein CN. An international survey of the use and attitudes regarding alternative medicine by patients with inflammatory bowel disease. Am J Gastroenterol 1999; 94:1298-1303. (Pubitemid 29214645)
20. Langmead L, Chitnis M, Rampton DS. Use of complementary therapies by patients with IBD may indicate psychosocial distress. Inflamm Bowel Dis 2002; 8:174-179. (Pubitemid 34546043)
21. Ganguli SC, Cawdron R, Irvine EJ. Alternative medicine use by Canadian ambulatory gastroenterology patients: secular trend or epidemic? Am J Gastroenterol 2004; 99:319-326. (Pubitemid 38279876)
22. Langhorst J, Anthonisen IB, Steder-Neukamm U, Ludtke R, Spahn G, Michalsen A, Dobos GJ. Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey. Inflamm Bowel Dis 2005; 11:287-295. (Pubitemid 40439683)
23. Kalant H. Adverse effects of cannabis on health: an update of the literature since 1996. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28:849-863. (Pubitemid 39195275)
24. Sidney S. Cardiovascular consequences of marijuana use. J Clin Pharmacol 2002; 42:64S-70S. (Pubitemid 35205048)
25. Reid PT, Macleod J, Robertson JR. Cannabis and the lung. J R Coll Edinb 2010; 40:328-333.
26. Thomas GA, Rhodes J, Ingram JR. Mechanisms of disease: nicotine-a review of its actions in the context of gastrointestinal disease. Nat Clin Pract Gastroenterol Hepatol 2005; 2:536-544. (Pubitemid 43135272)
27. Spurgeon D. Canadian doctors question marijuana for medicinal use. BMJ 2003; 327:122.
28. Kmietowicz Z. Cannabis based drug is licensed for spasticity in patients with MS. BMJ 2010; 340:c3363.